RTW INVESTMENTS, LP

Holdings History for Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

Symbol: TSHA on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned: 23,407,133 shares
Security Ownership %: 8.3%

Shares, Excluding Options vs Price

Value, Excluding Options

RTW Investments, LP ownership in Taysha Gene Therapies, Inc. Common Stock, par value $0.00001 per share (TSHA)

17 Feb 2026 - RTW Investments, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 23,407,133 shares of Taysha Gene Therapies, Inc. Common Stock, par value $0.00001 per share (TSHA). This represents 8.3% ownership of the company. In their previous filing dated 14 Aug 2025, RTW INVESTMENTS, LP had reported owning 25,183,287 shares, indicating a decrease of +7.1%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RTW Investments, LP	8.3%	-16%	$120,312,664	23,407,133	-1,776,154	-7.1%	$5.14	13G/A	31 Dec 2025	17 Feb 2026, 08:49
RTW Investments, LP	9.9%	-0.9%	$66,483,878	25,183,287	+4,509,980	+22%	$2.64	13G/A	30 Jun 2025	14 Aug 2025, 08:10
RTW Investments, LP	10%	+68%	$37,625,419	20,673,307	+8,304,973	+67%	$1.82	13G/A	31 Mar 2025	15 May 2025, 08:00
RTW Investments, LP	5.9%		$22,510,368	12,368,334			$1.82	13G/A	31 Dec 2024	14 Feb 2025, 09:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.9%	-0.44%	$90,190,634	16,398,297	-7,955,994	-33%	$5.50	Q4 2025
30 Sep 2025	0.98%	-0.03%	$79,638,532	24,354,291	-667,293	-2.7%	$3.27	Q3 2025
30 Jun 2025	0.82%	+0.21%	$57,799,859	25,021,584	+6,233,718	+33%	$2.31	Q2 2025
31 Mar 2025	0.4%	+0.22%	$26,115,134	18,787,866	+10,115,236	+100%	$1.39	Q1 2025
31 Dec 2024	0.23%	-0.16%	$15,003,650	8,672,630	-6,273,790	-42%	$1.73	Q4 2024
30 Sep 2024	0.43%	-0.11%	$30,042,304	14,946,420	-3,853,879	-20%	$2.01	Q3 2024
30 Jun 2024	0.65%	+0.01%	$42,112,670	18,800,299	+207,114	+1.1%	$2.24	Q2 2024
31 Mar 2024	0.79%	+0.07%	$53,362,441	18,593,185	+1,700,000	+10%	$2.87	Q1 2024
31 Dec 2023	0.47%	0%	$29,900,937	16,893,185	0		$1.77	Q4 2023
30 Sep 2023	1.1%	+1.1%	$53,382,465	16,893,185	+16,893,185	NEW	$3.16	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.